Addition of rituximab to CEAC conditioning for autologous hematopoietic stem cell transplantation provides no survival benefit in diffuse large B-Cell lymphoma: A propensity score-matched cohort study. - Fan C; Yang J; Peng Y; Hu J; Cao M; Li R; Jiang D; Wang T; Luo W; Chen L; Luo Y; Lu G (Annals of hematology, 2026)